Viewing Study NCT06561360


Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2025-12-26 @ 5:14 PM
Study NCT ID: NCT06561360
Status: RECRUITING
Last Update Posted: 2025-10-07
First Post: 2024-08-13
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Vemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People With Hairy Cell Leukemia (HCL)
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module